IL1RL-1 AS A CARDIOVASCULAR DISEASE MARKER AND THERAPEUTIC TARGET
1 Assignment
0 Petitions
Accused Products
Abstract
This invention pertains to methods and compositions for the diagnosis and treatment of cardiovascular conditions. More specifically, the invention relates to isolated molecules that can be used to diagnose and/or treat cardiovascular conditions including cardiac hypertrophy, myocardial infarction, stroke, arteriosclerosis, and heart failure.
-
Citations
43 Claims
-
1-33. -33. (canceled)
-
34. A method for evaluating the likelihood that a subject will benefit from treatment with an agent for reducing the risk of a cardiovascular condition, the method comprising:
-
obtaining a level of an Interleukin 1 Receptor-Like 1 (IL1RL-1) polypeptide in a sample comprising serum from the subject, and comparing the level of the IL1RL-1 polypeptide to a predetermined value, wherein the level of the IL1RL-1 polypeptide in comparison to the predetermined value is indicative of whether the subject will benefit from treatment with said agent. - View Dependent Claims (35, 36, 37, 38, 39, 40, 41, 42, 43)
-
Specification